Simris Group AB Appoints Professor Andreas Pahl as Chief Executive Officer
PRIVATEJul 15, 2026
New to company · from Heidelberg Pharma AG“he served as Chief Executive Officer of Heidelberg Pharma AG, having previously held the position of Chief Scientific Officer”
Position
Chief Executive Officer
Company
Simris Group AB
Professor Andreas Pahl
Financial ServicesFinanceLending
Description
Simris Group AB has announced the appointment of Professor Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, effective immediately. Professor Pahl brings over 25 years of experience in drug development and commercialization, particularly in the field of antibody-drug conjugates.
Who to call at Simris Group AB, and when
A new leader at Simris Group AB brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Simris Group AB raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Simris Group AB, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Simris Group AB. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Simris Group AB
About
Simris Group AB (publ) is a company focused on providing financing capital to drive its business forward. The company is preparing for a larger capital raise while optimizing its existing loan facilities. They aim to reduce running costs and enhance liquidity through strategic financing initiatives.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Simris Group AB changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
